Table of Contents 1 Acute Migraine Treatments Market Overview 1.1 Product Overview and Scope of Acute Migraine Treatments 1.2 Classification of Acute Migraine Treatments by Types 1.2.1 Global Acute Migraine Treatments Revenue Comparison by Types (2019-2024) 1.2.2 Global Acute Migraine Treatments Revenue Market Share by Types in 2018 1.2.3 Drugs 1.2.4 Patches 1.2.5 Others 1.3 Global Acute Migraine Treatments Market by Application 1.3.1 Global Acute Migraine Treatments Market Size and Market Share Comparison by Applications (2014-2024) 1.3.2 Hospital Pharmacies 1.3.3 Drug Stores 1.3.4 Retail Pharmacies 1.3.5 Online Pharmacies 1.4 Global Acute Migraine Treatments Market by Regions 1.4.1 Global Acute Migraine Treatments Market Size (Million USD) Comparison by Regions (2014-2024) 1.4.1 North America (USA, Canada and Mexico) Acute Migraine Treatments Status and Prospect (2014-2024) 1.4.2 Europe (Germany, France, UK, Russia and Italy) Acute Migraine Treatments Status and Prospect (2014-2024) 1.4.3 Asia-Pacific (China, Japan, Korea, India and Southeast Asia) Acute Migraine Treatments Status and Prospect (2014-2024) 1.4.4 South America (Brazil, Argentina, Colombia) Acute Migraine Treatments Status and Prospect (2014-2024) 1.4.5 Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa) Acute Migraine Treatments Status and Prospect (2014-2024) 1.5 Global Market Size of Acute Migraine Treatments (2014-2024) 2 Manufacturers Profiles 2.1 Amgen 2.1.1 Business Overview 2.1.2 Acute Migraine Treatments Type and Applications 2.1.2.1 Product A 2.1.2.2 Product B 2.1.3 Amgen Acute Migraine Treatments Revenue, Gross Margin and Market Share (2017-2018) 2.2 Pfizer 2.2.1 Business Overview 2.2.2 Acute Migraine Treatments Type and Applications 2.2.2.1 Product A 2.2.2.2 Product B 2.2.3 Pfizer Acute Migraine Treatments Revenue, Gross Margin and Market Share (2017-2018) 2.3 Novartis 2.3.1 Business Overview 2.3.2 Acute Migraine Treatments Type and Applications 2.3.2.1 Product A 2.3.2.2 Product B 2.3.3 Novartis Acute Migraine Treatments Revenue, Gross Margin and Market Share (2017-2018) 2.4 Eli Lily 2.4.1 Business Overview 2.4.2 Acute Migraine Treatments Type and Applications 2.4.2.1 Product A 2.4.2.2 Product B 2.4.3 Eli Lily Acute Migraine Treatments Revenue, Gross Margin and Market Share (2017-2018) 2.5 AstraZeneca 2.5.1 Business Overview 2.5.2 Acute Migraine Treatments Type and Applications 2.5.2.1 Product A 2.5.2.2 Product B 2.5.3 AstraZeneca Acute Migraine Treatments Revenue, Gross Margin and Market Share (2017-2018) 2.6 Teva Pharmaceutical 2.6.1 Business Overview 2.6.2 Acute Migraine Treatments Type and Applications 2.6.2.1 Product A 2.6.2.2 Product B 2.6.3 Teva Pharmaceutical Acute Migraine Treatments Revenue, Gross Margin and Market Share (2017-2018) 2.7 Allergan 2.7.1 Business Overview 2.7.2 Acute Migraine Treatments Type and Applications 2.7.2.1 Product A 2.7.2.2 Product B 2.7.3 Allergan Acute Migraine Treatments Revenue, Gross Margin and Market Share (2017-2018) 2.8 Abbott 2.8.1 Business Overview 2.8.2 Acute Migraine Treatments Type and Applications 2.8.2.1 Product A 2.8.2.2 Product B 2.8.3 Abbott Acute Migraine Treatments Revenue, Gross Margin and Market Share (2017-2018) 3 Global Acute Migraine Treatments Market Competition, by Players 3.1 Global Acute Migraine Treatments Revenue and Share by Players (2014-2019) 3.2 Market Concentration Rate 3.2.1 Top 5 Acute Migraine Treatments Players Market Share 3.2.2 Top 10 Acute Migraine Treatments Players Market Share 3.3 Market Competition Trend 4 Global Acute Migraine Treatments Market Size by Regions 4.1 Global Acute Migraine Treatments Revenue and Market Share by Regions 4.2 North America Acute Migraine Treatments Revenue and Growth Rate (2014-2019) 4.3 Europe Acute Migraine Treatments Revenue and Growth Rate (2014-2019) 4.4 Asia-Pacific Acute Migraine Treatments Revenue and Growth Rate (2014-2019) 4.5 South America Acute Migraine Treatments Revenue and Growth Rate (2014-2019) 4.6 Middle East and Africa Acute Migraine Treatments Revenue and Growth Rate (2014-2019) 5 North America Acute Migraine Treatments Revenue by Countries 5.1 North America Acute Migraine Treatments Revenue by Countries (2014-2019) 5.2 USA Acute Migraine Treatments Revenue and Growth Rate (2014-2019) 5.3 Canada Acute Migraine Treatments Revenue and Growth Rate (2014-2019) 5.4 Mexico Acute Migraine Treatments Revenue and Growth Rate (2014-2019) 6 Europe Acute Migraine Treatments Revenue by Countries 6.1 Europe Acute Migraine Treatments Revenue by Countries (2014-2019) 6.2 Germany Acute Migraine Treatments Revenue and Growth Rate (2014-2019) 6.3 UK Acute Migraine Treatments Revenue and Growth Rate (2014-2019) 6.4 France Acute Migraine Treatments Revenue and Growth Rate (2014-2019) 6.5 Russia Acute Migraine Treatments Revenue and Growth Rate (2014-2019) 6.6 Italy Acute Migraine Treatments Revenue and Growth Rate (2014-2019) 7 Asia-Pacific Acute Migraine Treatments Revenue by Countries 7.1 Asia-Pacific Acute Migraine Treatments Revenue by Countries (2014-2019) 7.2 China Acute Migraine Treatments Revenue and Growth Rate (2014-2019) 7.3 Japan Acute Migraine Treatments Revenue and Growth Rate (2014-2019) 7.4 Korea Acute Migraine Treatments Revenue and Growth Rate (2014-2019) 7.5 India Acute Migraine Treatments Revenue and Growth Rate (2014-2019) 7.6 Southeast Asia Acute Migraine Treatments Revenue and Growth Rate (2014-2019) 8 South America Acute Migraine Treatments Revenue by Countries 8.1 South America Acute Migraine Treatments Revenue by Countries (2014-2019) 8.2 Brazil Acute Migraine Treatments Revenue and Growth Rate (2014-2019) 8.3 Argentina Acute Migraine Treatments Revenue and Growth Rate (2014-2019) 8.4 Colombia Acute Migraine Treatments Revenue and Growth Rate (2014-2019) 9 Middle East and Africa Revenue Acute Migraine Treatments by Countries 9.1 Middle East and Africa Acute Migraine Treatments Revenue by Countries (2014-2019) 9.2 Saudi Arabia Acute Migraine Treatments Revenue and Growth Rate (2014-2019) 9.3 UAE Acute Migraine Treatments Revenue and Growth Rate (2014-2019) 9.4 Egypt Acute Migraine Treatments Revenue and Growth Rate (2014-2019) 9.5 Nigeria Acute Migraine Treatments Revenue and Growth Rate (2014-2019) 9.6 South Africa Acute Migraine Treatments Revenue and Growth Rate (2014-2019) 10 Global Acute Migraine Treatments Market Segment by Type 10.1 Global Acute Migraine Treatments Revenue and Market Share by Type (2014-2019) 10.2 Global Acute Migraine Treatments Market Forecast by Type (2019-2024) 10.3 Drugs Revenue Growth Rate (2014-2024) 10.4 Patches Revenue Growth Rate (2014-2024) 10.5 Others Revenue Growth Rate (2014-2024) 11 Global Acute Migraine Treatments Market Segment by Application 11.1 Global Acute Migraine Treatments Revenue Market Share by Application (2014-2019) 11.2 Acute Migraine Treatments Market Forecast by Application (2019-2024) 11.3 Hospital Pharmacies Revenue Growth (2014-2019) 11.4 Drug Stores Revenue Growth (2014-2019) 11.5 Retail Pharmacies Revenue Growth (2014-2019) 11.6 Online Pharmacies Revenue Growth (2014-2019) 12 Global Acute Migraine Treatments Market Size Forecast (2019-2024) 12.1 Global Acute Migraine Treatments Market Size Forecast (2019-2024) 12.2 Global Acute Migraine Treatments Market Forecast by Regions (2019-2024) 12.3 North America Acute Migraine Treatments Revenue Market Forecast (2019-2024) 12.4 Europe Acute Migraine Treatments Revenue Market Forecast (2019-2024) 12.5 Asia-Pacific Acute Migraine Treatments Revenue Market Forecast (2019-2024) 12.6 South America Acute Migraine Treatments Revenue Market Forecast (2019-2024) 12.7 Middle East and Africa Acute Migraine Treatments Revenue Market Forecast (2019-2024) 13 Research Findings and Conclusion 14 Appendix 14.1 Methodology 14.2 Data Source

Table of Contents 1 Acute Migraine Treatments Market Overview 1.1 Product Overview and Scope of Acute Migraine Treatments 1.2 Classification of Acute Migraine Treatments by Types 1.2.1 Global Acute Migraine Treatments Revenue Comparison by Types (2019-2024) 1.2.2 Global Acute Migraine Treatments Revenue Market Share by Types in 2018 1.2.3 Drugs 1.2.4 Patches 1.2.5 Others 1.3 Global Acute Migraine Treatments Market by Application 1.3.1 Global Acute Migraine Treatments Market Size and Market Share Comparison by Applications (2014-2024) 1.3.2 Hospital Pharmacies 1.3.3 Drug Stores 1.3.4 Retail Pharmacies 1.3.5 Online Pharmacies 1.4 Global Acute Migraine Treatments Market by Regions 1.4.1 Global Acute Migraine Treatments Market Size (Million USD) Comparison by Regions (2014-2024) 1.4.1 North America (USA, Canada and Mexico) Acute Migraine Treatments Status and Prospect (2014-2024) 1.4.2 Europe (Germany, France, UK, Russia and Italy) Acute Migraine Treatments Status and Prospect (2014-2024) 1.4.3 Asia-Pacific (China, Japan, Korea, India and Southeast Asia) Acute Migraine Treatments Status and Prospect (2014-2024) 1.4.4 South America (Brazil, Argentina, Colombia) Acute Migraine Treatments Status and Prospect (2014-2024) 1.4.5 Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa) Acute Migraine Treatments Status and Prospect (2014-2024) 1.5 Global Market Size of Acute Migraine Treatments (2014-2024) 2 Manufacturers Profiles 2.1 Amgen 2.1.1 Business Overview 2.1.2 Acute Migraine Treatments Type and Applications 2.1.2.1 Product A 2.1.2.2 Product B 2.1.3 Amgen Acute Migraine Treatments Revenue, Gross Margin and Market Share (2017-2018) 2.2 Pfizer 2.2.1 Business Overview 2.2.2 Acute Migraine Treatments Type and Applications 2.2.2.1 Product A 2.2.2.2 Product B 2.2.3 Pfizer Acute Migraine Treatments Revenue, Gross Margin and Market Share (2017-2018) 2.3 Novartis 2.3.1 Business Overview 2.3.2 Acute Migraine Treatments Type and Applications 2.3.2.1 Product A 2.3.2.2 Product B 2.3.3 Novartis Acute Migraine Treatments Revenue, Gross Margin and Market Share (2017-2018) 2.4 Eli Lily 2.4.1 Business Overview 2.4.2 Acute Migraine Treatments Type and Applications 2.4.2.1 Product A 2.4.2.2 Product B 2.4.3 Eli Lily Acute Migraine Treatments Revenue, Gross Margin and Market Share (2017-2018) 2.5 AstraZeneca 2.5.1 Business Overview 2.5.2 Acute Migraine Treatments Type and Applications 2.5.2.1 Product A 2.5.2.2 Product B 2.5.3 AstraZeneca Acute Migraine Treatments Revenue, Gross Margin and Market Share (2017-2018) 2.6 Teva Pharmaceutical 2.6.1 Business Overview 2.6.2 Acute Migraine Treatments Type and Applications 2.6.2.1 Product A 2.6.2.2 Product B 2.6.3 Teva Pharmaceutical Acute Migraine Treatments Revenue, Gross Margin and Market Share (2017-2018) 2.7 Allergan 2.7.1 Business Overview 2.7.2 Acute Migraine Treatments Type and Applications 2.7.2.1 Product A 2.7.2.2 Product B 2.7.3 Allergan Acute Migraine Treatments Revenue, Gross Margin and Market Share (2017-2018) 2.8 Abbott 2.8.1 Business Overview 2.8.2 Acute Migraine Treatments Type and Applications 2.8.2.1 Product A 2.8.2.2 Product B 2.8.3 Abbott Acute Migraine Treatments Revenue, Gross Margin and Market Share (2017-2018) 3 Global Acute Migraine Treatments Market Competition, by Players 3.1 Global Acute Migraine Treatments Revenue and Share by Players (2014-2019) 3.2 Market Concentration Rate 3.2.1 Top 5 Acute Migraine Treatments Players Market Share 3.2.2 Top 10 Acute Migraine Treatments Players Market Share 3.3 Market Competition Trend 4 Global Acute Migraine Treatments Market Size by Regions 4.1 Global Acute Migraine Treatments Revenue and Market Share by Regions 4.2 North America Acute Migraine Treatments Revenue and Growth Rate (2014-2019) 4.3 Europe Acute Migraine Treatments Revenue and Growth Rate (2014-2019) 4.4 Asia-Pacific Acute Migraine Treatments Revenue and Growth Rate (2014-2019) 4.5 South America Acute Migraine Treatments Revenue and Growth Rate (2014-2019) 4.6 Middle East and Africa Acute Migraine Treatments Revenue and Growth Rate (2014-2019) 5 North America Acute Migraine Treatments Revenue by Countries 5.1 North America Acute Migraine Treatments Revenue by Countries (2014-2019) 5.2 USA Acute Migraine Treatments Revenue and Growth Rate (2014-2019) 5.3 Canada Acute Migraine Treatments Revenue and Growth Rate (2014-2019) 5.4 Mexico Acute Migraine Treatments Revenue and Growth Rate (2014-2019) 6 Europe Acute Migraine Treatments Revenue by Countries 6.1 Europe Acute Migraine Treatments Revenue by Countries (2014-2019) 6.2 Germany Acute Migraine Treatments Revenue and Growth Rate (2014-2019) 6.3 UK Acute Migraine Treatments Revenue and Growth Rate (2014-2019) 6.4 France Acute Migraine Treatments Revenue and Growth Rate (2014-2019) 6.5 Russia Acute Migraine Treatments Revenue and Growth Rate (2014-2019) 6.6 Italy Acute Migraine Treatments Revenue and Growth Rate (2014-2019) 7 Asia-Pacific Acute Migraine Treatments Revenue by Countries 7.1 Asia-Pacific Acute Migraine Treatments Revenue by Countries (2014-2019) 7.2 China Acute Migraine Treatments Revenue and Growth Rate (2014-2019) 7.3 Japan Acute Migraine Treatments Revenue and Growth Rate (2014-2019) 7.4 Korea Acute Migraine Treatments Revenue and Growth Rate (2014-2019) 7.5 India Acute Migraine Treatments Revenue and Growth Rate (2014-2019) 7.6 Southeast Asia Acute Migraine Treatments Revenue and Growth Rate (2014-2019) 8 South America Acute Migraine Treatments Revenue by Countries 8.1 South America Acute Migraine Treatments Revenue by Countries (2014-2019) 8.2 Brazil Acute Migraine Treatments Revenue and Growth Rate (2014-2019) 8.3 Argentina Acute Migraine Treatments Revenue and Growth Rate (2014-2019) 8.4 Colombia Acute Migraine Treatments Revenue and Growth Rate (2014-2019) 9 Middle East and Africa Revenue Acute Migraine Treatments by Countries 9.1 Middle East and Africa Acute Migraine Treatments Revenue by Countries (2014-2019) 9.2 Saudi Arabia Acute Migraine Treatments Revenue and Growth Rate (2014-2019) 9.3 UAE Acute Migraine Treatments Revenue and Growth Rate (2014-2019) 9.4 Egypt Acute Migraine Treatments Revenue and Growth Rate (2014-2019) 9.5 Nigeria Acute Migraine Treatments Revenue and Growth Rate (2014-2019) 9.6 South Africa Acute Migraine Treatments Revenue and Growth Rate (2014-2019) 10 Global Acute Migraine Treatments Market Segment by Type 10.1 Global Acute Migraine Treatments Revenue and Market Share by Type (2014-2019) 10.2 Global Acute Migraine Treatments Market Forecast by Type (2019-2024) 10.3 Drugs Revenue Growth Rate (2014-2024) 10.4 Patches Revenue Growth Rate (2014-2024) 10.5 Others Revenue Growth Rate (2014-2024) 11 Global Acute Migraine Treatments Market Segment by Application 11.1 Global Acute Migraine Treatments Revenue Market Share by Application (2014-2019) 11.2 Acute Migraine Treatments Market Forecast by Application (2019-2024) 11.3 Hospital Pharmacies Revenue Growth (2014-2019) 11.4 Drug Stores Revenue Growth (2014-2019) 11.5 Retail Pharmacies Revenue Growth (2014-2019) 11.6 Online Pharmacies Revenue Growth (2014-2019) 12 Global Acute Migraine Treatments Market Size Forecast (2019-2024) 12.1 Global Acute Migraine Treatments Market Size Forecast (2019-2024) 12.2 Global Acute Migraine Treatments Market Forecast by Regions (2019-2024) 12.3 North America Acute Migraine Treatments Revenue Market Forecast (2019-2024) 12.4 Europe Acute Migraine Treatments Revenue Market Forecast (2019-2024) 12.5 Asia-Pacific Acute Migraine Treatments Revenue Market Forecast (2019-2024) 12.6 South America Acute Migraine Treatments Revenue Market Forecast (2019-2024) 12.7 Middle East and Africa Acute Migraine Treatments Revenue Market Forecast (2019-2024) 13 Research Findings and Conclusion 14 Appendix 14.1 Methodology 14.2 Data Source

Amgen Pfizer Novartis Eli Lily AstraZeneca Teva Pharmaceutical Allergan Abbott